Revelation Biosciences sets 1-for-7 reverse stock split effective October 20, 2026
REVB•Revelation Biosciences will implement a 1-for-7 reverse stock split effective October 20, 2026, with split-adjusted trading under its existing symbol, REVB. The company said the split aims to raise its share price to regain compliance with Nasdaq Capital Market’s minimum bid requirement.
1. Reverse split details
Revelation Biosciences will implement a 1-for-7 reverse stock split effective October 20, 2026. Shares will begin trading on a split-adjusted basis that day under the existing symbol REVB, and fractional shares will be rounded up to the nearest whole share.
2. Nasdaq compliance aim
The company said the split aims to raise its share price to regain compliance with Nasdaq Capital Market’s minimum bid requirement.
